James Mullmann has been awarded an NIH F30 Fellowship for his project “Elucidating the tumor suppressive effects of the sirtuin, SIRT1, in triple-negative breast cancer.” Congratulations, James!
James Mullmann awarded NIH F30 Fellowship
on on on